A Study to Characterize the Prevalence of Overweight and Obesity Among Patients With Established Cardiovascular Disease
Completed
Conditions studied: Obesity, Overweight
In brief
The purpose of this observational study is to measure how many people are overweight or obese amongst patients with a diagnosed cardiovascular disease (CVD). The study also aims to characterise the population including the presence of cardiovascular (CV) risk factors in a number of countries across the globe representing different geographies, ethnicities, as well as different healthcare systems.
Key facts
- Study ID
- NCT05873660
- Run by
- Novo Nordisk A/S
- People needed
- 5360
- Starts
- 2023-06-12
- Expected to finish
- 2024-06-24
- Last updated by the study team
- 2024-07-11
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Informed consent obtained before any study-related activities (study-related activities are any procedure related to recording of data according to the protocol).
- Adults, age above or equal to 18 years at the time of signing informed consent.
- Have established CVD and equal to or greater than 1 follow up appointment following an acute event from at least one of the following:
- Prior myocardial infarction
- Prior stroke (ischemic or haemorrhagic stroke)
- Symptomatic peripheral arterial disease (PAD), as evidenced by intermittent claudication with ankle-brachial index (ABI) below 85 (at rest), or peripheral arterial revascularization procedure, or amputation due to atherosclerotic disease
You may not qualify if…
- Previous participation in this study. Participation is defined as having given informed consent in this study
- Mental incapacity, unwillingness or language barriers precluding adequate understanding or cooperation
- Patients with known congenital heart disease/malformation
Where it is running
- Novo Nordisk Investigational Site — Plainsboro, New Jersey, United States
- Novo Nordisk Investigational Site — São Paulo, Brazil
- Novo Nordisk Investigational Site — Ontario, Canada
- Novo Nordisk Investigational Site — Riyadh, Saudi Arabia
- Novo Nordisk Investigational Site — Madrid, Spain
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.